1887

Journal of General Virology header logo

Volume 86, Issue 12

Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties Free

Abstract

The strategy of RNA interference (RNAi)-based gene silencing has been suggested to have great potential in treating viral diseases. It provides new hope of being able to complement the limited therapeutic options currently available for chronic hepatitis B virus (HBV) infection. To advance such a strategy towards clinical use, the effects of various parameters on the anti-HBV efficiency of RNAi need to be well-defined. In this study, the efficacy and pharmacodynamic properties of different RNAi target sequences and constructs were examined. Several sequences were found to be effective in cell and animal models, achieving inhibition rates of approximately 80–90 %. Methyl-modified small interfering RNA (siRNA) molecules were found to be more stable inside cells than natural siRNA molecules and offered longer-lasting inhibitory effects. Both were effective at rather low doses (an equimolar ratio with HBV preS2–S protein expression vector). Plasmid DNA vectors were less dose-responsive, but their effectiveness lasted longer, for approximately 1 month. By analysing these different parameters and their possible mechanisms, some important issues in RNAi therapeutics that should assist the future development of clinical applications have been addressed.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81171-0
2005-12-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/12/3227.html?itemId=/content/journal/jgv/10.1099/vir.0.81171-0&mimeType=html&fmt=ahah

References

  1. Adelman Z. N., Blair C. D., Carlson J. O., Beaty B. J., Olson K. E. 2001; Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 10:265–273 [CrossRef]
     [Google Scholar]
  2. Aihara H., Miyazaki J. 1998; Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867–870 [CrossRef]
     [Google Scholar]
  3. Aoki Y., Cioca D. P., Oidaira H., Kamiya J., Kiyosawa K. 2003; RNA interference may be more potent than antisense RNA in human cancer cell lines. Clin Exp Pharmacol Physiol 30:96–102 [CrossRef]
     [Google Scholar]
  4. Brummelkamp T. R., Bernards R., Agami R. 2002; A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553 [CrossRef]
     [Google Scholar]
  5. Carreno V., Castillo I., Molina J., Porres J. C., Bartolome J. 1992; Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 15:102–106 [CrossRef]
     [Google Scholar]
  6. Chiu Y.-L., Rana T. M. 2003; siRNA function in RNAi: a chemical modification analysis. RNA 9:1034–1048 [CrossRef]
     [Google Scholar]
  7. Czauderna F., Fechtner M., Dames S., Aygün H., Klippel A., Pronk G. J., Giese K., Kaufmann J. 2003; Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31:2705–2716 [CrossRef]
     [Google Scholar]
  8. Dienstag J. L., Cianciara J., Karayalcin S., Kowdley K. V., Willems B., Plisek S., Woessner M., Gardner S., Schiff E. 2003; Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 37:748–755 [CrossRef]
     [Google Scholar]
  9. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O., Galun E. 2003; Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769–776 [CrossRef]
     [Google Scholar]
  10. Gitlin L., Karelsky S., Andino R. 2002; Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430–434 [CrossRef]
     [Google Scholar]
  11. Goodarzi G., Gross S. C., Tewari A., Watabe K. 1990; Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. J Gen Virol 71:3021–3025 [CrossRef]
     [Google Scholar]
  12. Haasnoot P. C. J., Cupac D., Berkhout B. 2003; Inhibition of virus replication by RNA interference. J Biomed Sci 10:607–616 [CrossRef]
     [Google Scholar]
  13. Hamasaki K., Nakao K., Matsumoto K., Ichikawa T., Ishikawa H., Eguchi K. 2003; Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 543:51–54 [CrossRef]
     [Google Scholar]
  14. He X., Chen G., Huang Y. 2003; Construction and identification of therapeutic double plasmid HBV DNA vaccine. Med J Chin PLA 28:493–496
     [Google Scholar]
  15. Jacque J.-M., Triques K., Stevenson M. 2002; Modulation of HIV-1 replication by RNA interference. Nature 418:435–438 [CrossRef]
     [Google Scholar]
  16. Lai C., Ching C., Tung A. K., Li E., Young J., Hill A., Wong B. C., Dent J., Wu P. 1997; Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 25:241–244 [CrossRef]
     [Google Scholar]
  17. Lee N. S., Dohjima T., Bauer G., Li H., Li M.-J., Ehsani A., Salvaterra P., Rossi J. 2002; Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20:500–505
     [Google Scholar]
  18. Liu F., Song Y. K., Liu D. 1999; Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6:1258–1266 [CrossRef]
     [Google Scholar]
  19. Lok A. S. 2002; Chronic hepatitis B. N Engl J Med 346:1682–1683 [CrossRef]
     [Google Scholar]
  20. Marathe R., Anandalakshmi R., Smith T. H., Pruss G. J., Vance V. B. 2000; RNA viruses as inducers, suppressors and targets of post-transcriptional gene silencing. Plant Mol Biol 43:295–306 [CrossRef]
     [Google Scholar]
  21. McCaffrey A. P., Nakai H., Pandey K., Huang Z., Salazar F. H., Xu H., Wieland S. F., Marion P. L., Kay M. A. 2003; Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21:639–644 [CrossRef]
     [Google Scholar]
  22. Morrissey D. V., Lockridge J. A., Shaw L. 16 other authors 2005; Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23:1002–1007 [CrossRef]
     [Google Scholar]
  23. Rols M.-P., Delteil C., Golzio M., Dumond P., Cros S., Teissie J. 1998; In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168–171 [CrossRef]
     [Google Scholar]
  24. Sells M. A., Chen M.-L., Acs G. 1987; Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84:1005–1009 [CrossRef]
     [Google Scholar]
  25. Shlomai A., Shaul Y. 2003; Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37:764–770 [CrossRef]
     [Google Scholar]
  26. Soutschek J., Akinc A., Bramlage B. 22 other authors 2004; Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173–178 [CrossRef]
     [Google Scholar]
  27. Tipples G. A., Ma M. M., Fischer K. P., Bain V. G., Kneteman N. M., Tyrrell D. L. J. 1996; Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo . Hepatology 24:714–717
     [Google Scholar]
  28. Uprichard S. L., Boyd B., Althage A., Chisari F. V. 2005; Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci U S A 102:773–778 [CrossRef]
     [Google Scholar]
  29. von Weizsacker F., Blum H. E., Wands J. R. 1992; Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. Biochem Biophys Res Commun 189:743–748 [CrossRef]
     [Google Scholar]
  30. Wilson J. A., Jayasena S., Khvorova A. 7 other authors 2003; RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci U S A 100:2783–2788 [CrossRef]
     [Google Scholar]
  31. Yang D., Lu H., Erickson J. W. 2000; Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr Biol 10:1191–1200 [CrossRef]
     [Google Scholar]
  32. Ying C., De Clercq E., Neyts J. 2003; Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun 309:482–484 [CrossRef]
     [Google Scholar]
  33. Zhang G., Budker V., Wolff J. A. 1999; High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 10:1735–1737 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81171-0
Loading
Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties
J. Gen. Virol. 86, 3227 (2005); https://doi.org/10.1099/vir.0.81171-0
/content/journal/jgv/10.1099/vir.0.81171-0
/content/journal/jgv/10.1099/vir.0.81171-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error